News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
26,102 Results
Type
Article (1137)
Company Profile (3)
Press Release (24972)
Section
Business (12105)
Career Advice (17)
Deals (2157)
Drug Delivery (6)
Drug Development (2837)
Employer Resources (3)
FDA (585)
Job Trends (654)
News (15556)
Policy (785)
Tag
Academia (44)
Accelerated approval (2)
ADA (4)
Adcomms (1)
Allergies (5)
Alliances (967)
ALS (12)
Alzheimer's disease (55)
Antibody-drug conjugate (ADC) (32)
Approvals (642)
Artificial intelligence (26)
ASCO (11)
Autoimmune disease (23)
Automation (2)
Bankruptcy (16)
Best Places to Work (555)
BIO (1)
Biosimilars (7)
BioSpace Insights (3)
Biotechnology (2)
Bladder cancer (11)
Breast cancer (81)
Cancer (371)
Cardiovascular disease (29)
Career advice (16)
Career pathing (2)
CAR-T (4)
CDC (1)
CDMO (4)
Cell therapy (26)
Cervical cancer (3)
Clinical research (2895)
Collaboration (69)
Compensation (84)
Complete response letters (1)
COVID-19 (65)
CRISPR (1)
C-suite (19)
Cystic fibrosis (7)
Data (504)
Depression (4)
Dermatology (7)
Diabetes (40)
Diagnostics (318)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (9)
Drug pricing (11)
Drug shortages (3)
Duchenne muscular dystrophy (16)
Earnings (10699)
Editorial (2)
Employer resources (2)
Events (1871)
Executive appointments (18)
FDA (851)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (2)
Funding (81)
Gene editing (9)
Generative AI (2)
Gene therapy (21)
GLP-1 (70)
Government (106)
Guidances (118)
Healthcare (781)
Hematology (13)
HIV (10)
Immunology and inflammation (16)
Immuno-oncology (6)
Indications (12)
Infectious disease (80)
Inflammatory bowel disease (13)
Influenza (4)
Intellectual property (6)
Interviews (2)
IPO (1535)
Job creations (129)
Job search strategy (15)
JPM (4)
Kidney cancer (2)
Labor market (14)
Layoffs (44)
Legal (132)
Licensing (1)
Liver cancer (2)
Lung cancer (64)
Lymphoma (49)
Manufacturing (40)
Marketing (2)
MASH (7)
Medical device (636)
Medtech (647)
Mergers & acquisitions (673)
Metabolic disorders (107)
mRNA (6)
Multiple sclerosis (17)
NASH (1)
Neurodegenerative disease (12)
Neuropsychiatric disorders (5)
Neuroscience (120)
NextGen: Class of 2026 (176)
Non-profit (108)
Now hiring (2)
Obesity (59)
Opinion (4)
Ovarian cancer (12)
Pain (11)
Pancreatic cancer (22)
Parkinson's disease (6)
Partnered (1)
Patents (15)
Patient recruitment (8)
Peanut (3)
People (620)
Pharmacy benefit managers (2)
Phase 1 (655)
Phase 2 (1227)
Phase 3 (1200)
Pipeline (1118)
Policy (3)
Postmarket research (131)
Preclinical (135)
Press Release (1)
Prostate cancer (9)
Psychedelics (2)
Radiopharmaceuticals (12)
Rare diseases (46)
Real estate (133)
Recruiting (2)
Regulatory (772)
Reports (7)
Research institute (44)
Resumes & cover letters (4)
RNA editing (1)
RSV (5)
Schizophrenia (11)
Series A (8)
Series B (12)
Sickle cell disease (7)
Spinal muscular atrophy (17)
Startups (98)
Stomach cancer (1)
Supply chain (2)
Tariffs (5)
The Weekly (1)
Vaccines (21)
Venture capital (7)
Weight loss (39)
Women's health (7)
Date
Today (1)
Last 7 days (17)
Last 30 days (108)
Last 365 days (1708)
2026 (1186)
2025 (1758)
2024 (1879)
2023 (1993)
2022 (2197)
2021 (2172)
2020 (2101)
2019 (1639)
2018 (1420)
2017 (1256)
2016 (913)
2015 (1063)
2014 (748)
2013 (583)
2012 (588)
2011 (673)
2010 (604)
Location
Africa (18)
Alabama (1)
Arizona (13)
Asia (1487)
Australia (151)
California (802)
Canada (161)
China (88)
Colorado (32)
Connecticut (34)
Delaware (90)
Europe (3331)
Florida (108)
Georgia (33)
Idaho (3)
Illinois (87)
India (6)
Indiana (89)
Japan (45)
Kansas (8)
Kentucky (5)
Louisiana (8)
Maine (7)
Maryland (89)
Massachusetts (494)
Michigan (22)
Minnesota (30)
Missouri (5)
Montana (1)
Nevada (5)
New Hampshire (10)
New Jersey (292)
New Mexico (2)
New York (211)
North Carolina (87)
Northern California (478)
Ohio (23)
Oregon (1)
Pennsylvania (161)
Puerto Rico (2)
Rhode Island (1)
South America (44)
South Carolina (5)
Southern California (268)
Tennessee (10)
Texas (113)
United States (2881)
Utah (28)
Virginia (19)
Washington D.C. (2)
Washington State (60)
Wisconsin (6)
26,102 Results for "125".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing
August 6, 2026
·
4 min read
Funding
US to grant up to $125M for personalized RNA manufacturing innovation
A new program from ARPA-H has devoted funding to make individualized RNA-based genetic medicine more efficient to produce and improve accessibility.
September 3, 2026
·
2 min read
·
Michael Gibney
Bankruptcy
BioXcel files for bankruptcy, plans to sell assets to Teva for up to $125M
Teva Pharmaceuticals is the ‘stalking horse bidder’ to kick off the auction process for BioXcel Therapeutics’ AI-derived assets as the biotech files for Chapter 11 bankruptcy.
August 28, 2026
·
2 min read
·
Michael Gibney
Press Releases
Neurogene Inc. Announces Pricing of $125 Million Public Offering
July 1, 2026
·
6 min read
Press Releases
Skye Bioscience and Redx Pharma Announce Transaction Agreement and $125 Million in Financings
August 16, 2026
·
21 min read
Press Releases
Cell and Gene Therapy CDMO Market to Hit Around USD 125.09 Bn by 2035
April 15, 2026
·
1 min read
Press Releases
OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests
August 13, 2026
·
4 min read
Funding
SonoThera bags $125M series B to advance safer gene therapies
Instead of using viral vectors, SonoThera’s genetic medicines are delivered through an ultrasound-mediated technology that could help sidestep key safety issues with conventional delivery methods.
June 11, 2026
·
2 min read
·
Tristan Manalac
Immunology and inflammation
J&J Stops Mid-stage Eczema Trial as $1.25B Asset Misses Efficacy Mark
J&J paid Numab Therapeutics $1.25 billion upfront for the asset in 2024 based on the belief that its dual mechanism of action could improve on existing therapies.
January 5, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Conavi Medical Receives $1.25 Million Milestone Payment Under Ontario Life Sciences Scale-Up Fund
June 29, 2026
·
5 min read
1 of 2,611
Next
